Ascendis Pharma A (ASND) Short-term Investments (2020 - 2023)

Ascendis Pharma A has disclosed Short-term Investments across 4 years of filings, most recently posting $7.8 million for Q4 2023.

• Short-term Investments for Q4 2023 came in at $7.8 million, down 54.76% year-over-year; the trailing twelve-month figure through Dec 2023 was $7.8 million (down 54.76% YoY), and the FY2023 annual result was $7.8 million, down 54.76% from the prior year.
• Short-term Investments came in at $7.8 million for Q4 2023 at Ascendis Pharma A, down from $17.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $350.5 million in Q1 2020 to a low of $1.3 million in Q1 2022.
• The 4-year median for Short-term Investments is $5.2 million (2021), against an average of $46.2 million.
• Across the five-year window, Short-term Investments plunged 97.21% in 2021 and jumped 233.77% in 2022, its largest moves.
• Ascendis Pharma A's Short-term Investments stood at $3.2 million in 2020, then surged by 64.36% to $5.2 million in 2021, then surged by 233.77% to $17.3 million in 2022, then sank by 54.76% to $7.8 million in 2023.
• The last three Short-term Investments figures came in at $7.8 million (Q4 2023), $17.3 million (Q4 2022), and $4.3 million (Q3 2022), per Business Quant data.